MC Dunn, DA Knight… - Antiviral therapy, 2011 - ncbi.nlm.nih.gov BACKGROUND: Respiratory syncytial virus (RSV) is the primary cause of bronchiolitis and pneumonia in infants and young children worldwide and is often the cause of infections in bone marrow, solid organ transplant, cystic fibrosis and congenital heart disease patients, as well as ... Cited by 1 - All 3 versions
[PDF] from biomedcentral.comM Kverka, P Rossmann… - BMC …, 2011 - biomedcentral.com Miloslav Kverka (kverka@biomed.cas.cz) Pavel Rossmann (RossmannP@seznam.cz) Helena Tlaskalova-Hogenova (tlaskalo@biomed.cas.cz) Klara Klimesova (klimesov@biomed.cas.cz ) Bindia Jharap (B.Jharap@vumc.nl) Nanne K de Boer (KHN.deBoer@vumc.nl) Rene M ... Related articles - All 6 versions
N Mori, Y Shimomukai, T Yokooji, M Ishiguro… - Pharmazie, 2011 - Govi-Verlag The characteristics of intestinal absorption of mizoribine and cephalexin, that are mediated by concentrative nucleoside transporters (CNTs) and PEPT1, respectively, was examined in lipopolysaccharide (LPS)-treated rats. LPS treatment is known to modify the expression of some transporters ... Related articles - All 3 versions
N Tsankov… - Journal of Dermatological …, 2011 - informahealthcare.com The immunosuppressive properties of rifampicin have been discussed in the literature for more than 30 years. Paunescu suggested that rifampicin exhibits immunosuppressive properties both in vitro and in vivo (1). The authors found an effect on antibody production and certain cell- ... Related articles - All 3 versions
Y Yamada, K Ohkusu, M Yanagihara… - … and Infectious Disease, 2011 - Elsevier ... laboratory data. Consequently, she began treatment with an oral corticosteroid (prednisolone 40 mg every day) and an intravenous immunosuppressiveagent (cyclophosphamide 400 mg twice during hospitalization). Since the ... All 3 versions